Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amphastar Pharmaceuticals

23.93
+0.43001.83%
Post-market: 24.120.1900+0.79%19:31 EDT
Volume:524.82K
Turnover:12.45M
Market Cap:1.14B
PE:7.82
High:24.01
Open:23.71
Low:23.17
Close:23.50
Loading ...

BofA Adjusts Price Target on Amphastar Pharmaceuticals to $31 From $36

MT Newswires Live
·
21 Apr

Amphastar Pharmaceuticals Inc : Bofa Global Research Cuts Price Objective to $31 From $36

THOMSON REUTERS
·
21 Apr

Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Pharma Stock to Buy for Long Term Growth?

Insider Monkey
·
16 Apr

2 Reasons to Like AMPH and 1 to Stay Skeptical

StockStory
·
15 Apr

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award

ACCESS Newswire
·
28 Mar

Amphastar Pharmaceuticals Is Maintained at Neutral by Piper Sandler

Dow Jones
·
21 Mar

On Nasdaq, I Prefer the Less-Famous Stocks

GuruFocus.com
·
18 Mar

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

StockStory
·
13 Mar

Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference

ACCESS Newswire
·
05 Mar

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

StockStory
·
05 Mar

Amphastar Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
01 Mar

Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Small Cap Pharma Stocks to Buy Now?

Insider Monkey
·
01 Mar

Amphastar price target lowered to $36 from $44 at BofA

TIPRANKS
·
01 Mar

Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds

Benzinga
·
01 Mar

Amphastar Pharmaceuticals Inc (AMPH) Q4 2024 Earnings Call Highlights: Revenue Growth and ...

GuruFocus.com
·
01 Mar

Amphastar (AMPH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks
·
28 Feb

Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates

Zacks
·
28 Feb

Amphastar: Q4 Earnings Snapshot

Associated Press Finance
·
28 Feb

Stock Track | Amphastar Pharmaceuticals Plunges 10% After Q4 Earnings Miss on Higher Costs

Stock Track
·
28 Feb

Amphastar Pharma Q4 2024 Adj. EPS $0.92 Misses $0.94 Estimate, Sales $186.500M Miss $188.810M Estimate

Benzinga
·
28 Feb